UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 11, 2022 (May 10, 2022)

 

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware		001-15925		13-3893191
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification No.)

4000 Meridian Boulevard

Franklin, Tennessee 37067

(Address of principal executive offices)

Registrant’s telephone number, including area code: (615) 465-7000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		CYH		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07.

Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting on May 10, 2022. At the Annual Meeting, the stockholders voted on three proposals, each of which is described more fully in the Company’s Proxy Statement for the Annual Meeting. The following describes the matters that were submitted to the vote of the stockholders of the Company at the Annual Meeting and the result of the votes on these matters:

(1) The stockholders elected each of the following persons as directors of the Company for terms that expire at the 2023 annual meeting of stockholders of the Company and until their respective successors have been elected and have qualified:

 

Name		For				Against				Abstain				Broker Non-Votes
(a) Susan W. Brooks			102,144,299				105,576				66,775				14,794,007
(b) John A. Clerico			99,875,854				2,373,877				66,919				14,794,007
(c) Michael Dinkins			100,698,044				1,552,067				66,539				14,794,007
(d) James S. Ely III			99,837,532				2,411,899				67,219				14,794,007
(e) John A. Fry			97,519,129				4,730,201				67,320				14,794,007
(f) Joseph A. Hastings, D.M.D.			101,844,695				404,420				67,535				14,794,007
(g) Tim L. Hingtgen			100,517,413				1,736,554				62,683				14,794,007
(h) Elizabeth T. Hirsch			100,694,656				1,554,987				67,007				14,794,007
(i) William Norris Jennings, M.D.			99,554,735				2,694,928				66,987				14,794,007
(j) K. Ranga Krishnan, MBBS			99,804,672				2,446,395				65,583				14,794,007
(k) Wayne T. Smith			99,879,252				2,395,362				42,036				14,794,007
(l) H. James Williams, Ph.D.			100,714,278				1,532,924				69,448				14,794,007

(2) The stockholders approved the advisory resolution regarding the Company’s executive compensation:

 

For		Against		Abstain		Broker Non-Votes
100,172,311		1,960,194		184,145		14,794,007

(3) The stockholders ratified the appointment of Deloitte & Touche LLP, as the Company’s independent registered public accountants for 2022:

 

For		Against		Abstain		Broker Non-Votes
116,073,567		1,000,220		36,870		n/a

 

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 11, 2022				COMMUNITY HEALTH SYSTEMS, INC
				(Registrant)
				By:		/s/ Christopher G. Cobb
						Christopher G. Cobb
						Vice President – Legal and Corporate Secretary

 

3